EdgarLookup

Vaxart, Inc. — SC 13D/A Filings

53 SC 13D/A filings on record

This page lists all SC 13D/A filings submitted to the SEC by Vaxart, Inc. (VXRT), sorted by most recent first. Each row links to the full filing on EdgarLookup. Vaxart, Inc. has filed 53 SC 13D/A documents with the SEC since 2010. To view all SEC filings by Vaxart, Inc., see the full filings list.

Overview All Filings Financials Insiders
All 10-C 10-K 10-K/A 10-K405 10-Q 10-Q/A 11-K 144 15-15D 25-NSE 3 3/A 4 4/A 424B1 424B2 424B3 424B4 424B5 425 5 5/A 8-A12B 8-A12G 8-K 8-K/A ARS CORRESP CT ORDER DEF 14A DEFA14A DEFC14A DEFM14A DFAN14A EFFECT FWP NO ACT NT 10-K NT 10-Q POS AM PRE 14A PREC14A PREM14A PREN14A PRER14A PRRN14A PX14A6G REGDEX S-1 S-1/A S-3 S-3/A S-3ASR S-4 S-4/A S-8 S-8 POS SC 13D SC 13D/A SC 13G SC 13G/A SC TO-I SC TO-I/A SCHEDULE 13G SEC STAFF LETTER UPLOAD
Form Description Accession Number Filed Period
SC 13D/A 0000919574-20-004388 Jun 30, 2020
SC 13D/A 0000919574-20-003994 Jun 9, 2020
SC 13D/A 0000919574-20-003841 May 27, 2020
SC 13D/A 0000919574-20-003751 May 18, 2020
SC 13D/A 0000919574-20-003143 May 5, 2020
SC 13D/A 0000919574-19-007428 Nov 22, 2019
SC 13D/A SC 13D/A 0000919574-19-006691 Nov 1, 2019
SC 13D/A 0000919574-19-006275 Oct 8, 2019
SC 13D/A AMENDMENT NO. 2 TO THE SCHEDULE 13D 0000921895-18-000563 Feb 13, 2018
SC 13D/A SC 13D/A 0001019056-18-000159 Jan 18, 2018
SC 13D/A AMENDMENT NO. 1 TO THE SCHEDULE 13D 0000921895-18-000161 Jan 16, 2018
SC 13D/A SC 13D/A 0001019056-17-000749 Nov 9, 2017
SC 13D/A AMENDMENT NO. 1 0000921895-13-000424 Feb 15, 2013
SC 13D/A 0000807249-12-000352 Nov 20, 2012
SC 13D/A 0001521536-12-000698 Aug 1, 2012
SC 13D/A AMENDMENT NO. 2 TO THE SCHEDULE 13D 0001521536-12-000670 Jul 26, 2012
SC 13D/A AMENDMENT NO. 1 TO THE SCHEDULE 13D 0000921895-12-001516 Jul 17, 2012
SC 13D/A 0000919574-12-000171 Jan 13, 2012
SC 13D/A AMENDMENT NO. 19 0000899140-11-000319 May 26, 2011
SC 13D/A AMENDMENT NO. 18 0000899140-11-000252 Apr 6, 2011
SC 13D/A 17TH AMENDMENT 0000899140-10-000815 Dec 20, 2010
SC 13D/A SC 13D/A 0001104659-10-035002 Jun 22, 2010
SC 13D/A AMENDMENT NO. 16 0000899140-10-000422 May 20, 2010
SC 13D/A 15TH AMENDMENT 0000899140-10-000308 Apr 15, 2010
SC 13D/A 14TH AMENDMENT 0000899140-10-000251 Mar 30, 2010
SC 13D/A 14TH AMENDMENT 0000899140-10-000252 Mar 30, 2010
SC 13D/A MARCH 30, 2010 0001013594-10-000488 Mar 30, 2010
SC 13D/A SC 13D/A 0001104659-10-006033 Feb 10, 2010
SC 13D/A AMENDMENT NO. 13 0000899140-09-001768 Nov 23, 2009
SC 13D/A SC 13D/A 0001104659-09-004324 Jan 27, 2009
SC 13D/A 12TH AMENDMENT 0000899140-09-000025 Jan 6, 2009
SC 13D/A FEBRUARY 29, 2008 0001013594-08-000210 Feb 29, 2008
SC 13D/A CHAPMAN CAPITAL NABI SC 13D/A4 12-07-2007 0001365417-07-000087 Dec 7, 2007
SC 13D/A CHAPMAN CAPITAL NABI SC 13D/A3 07-30-2007 0001365417-07-000056 Jul 30, 2007
SC 13D/A CHAPMAN CAPITAL NABI SC 13D/A2 07-11-2007 0001365417-07-000052 Jul 11, 2007
SC 13D/A CHAPMAN CAPITAL NABI SC 13D/A1 06-18-2007 0001365417-07-000041 Jun 18, 2007
SC 13D/A 0000899140-07-000946 May 11, 2007
SC 13D/A 0000899140-06-001614 Nov 13, 2006
SC 13D/A SCHEDULE 13D/A 0001125282-06-006632 Oct 31, 2006
SC 13D/A 0000899140-06-001391 Oct 16, 2006
SC 13D/A AMENDMENT 0001104659-06-065683 Oct 10, 2006
SC 13D/A AMENDMENT NO. 7 0000899140-06-001366 Oct 4, 2006
SC 13D/A SIXTH AMENDMENT 0000899140-06-001336 Sep 26, 2006
SC 13D/A FIFTH AMENDMENT 0000899140-06-001325 Sep 14, 2006
SC 13D/A AMENDMENT NO. 4 0000899140-06-001280 Sep 5, 2006
SC 13D/A THIRD AMENDMENT 0000899140-06-001234 Aug 16, 2006
SC 13D/A SECOND AMENDMENT 0000899140-06-000866 Jun 15, 2006
SC 13D/A AMENDMENT 0001104659-06-035519 May 17, 2006
SC 13D/A NABI BIOPHARMACEUTICALS SC13D/A 05/05/06 0000902664-06-001386 May 8, 2006
SC 13D/A AMENDMENT 0001104659-06-031292 May 5, 2006